AI assistant
Sending…
CME GROUP INC. — Director's Dealing 2017
Mar 17, 2017
29871_dirs_2017-03-17_4be41abc-e733-47ae-ad18-108f2435bdb7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2017-03-15
Reporting Person: Tully Sean (Sr MD Global Hd Fin & OTC Prod)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-15 | Common Stock Class A | F | 698 | $124.74 | Disposed | 25678 | Direct |
| 2017-03-15 | Common Stock Class A | A | 1884 | $0.0 | Acquired | 27562 | Direct |
| 2017-03-16 | Common Stock Class A | F | 104 | $124.74 | Disposed | 27458 | Direct |
Footnotes
F1: Mr. Tully surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.
F2: Represents shares earned from a 2013 performance share award based upon the company's achievement of cash earnings per share growth and total shareholder return relative to the S&P 500 measured over 2014-2016.
F3: Mr. Tully surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/16/2017.
More from CME GROUP INC.
Proxy Solicitation & Information Statement
2026
May 19
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
Apr 24
Earnings Release
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Remuneration Information
2026
Mar 23
Annual Report
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17